Learn about the JEECUP 2026 Syllabus, including group-wise topics, weightage, prep tips, and much more on this page.

Human–elephant conflict (HEC) in Sri Lanka results in significant loss of human life, elephant deaths, and extensive damage to crops and property. Despite numerous interventions over the decades, the ...

Sri Lanka stands at a geopolitical crossroads where geography is both its greatest asset and its most vulnerable liability. Sitting astride the Indian Ocean’s critical east-west highway, the waters, ...

Forward contract cover locked in for 99% of 2026 and 81% of 2027. Earnings, cashflow, forward visibility, and return of capital to shareholders ...

(NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company ” or “JD.com ”), a leading supply chain-based technology and service provider, today announced its unaudited financial ...

Transitioned to a pure-play industrial REIT; Attractive development properties completed; Strong leasing activityTORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Nexus Industrial REIT (the “REIT”) (TSX: ...

Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced its unaudited financial results for the fourth quarter and fiscal ...

Franchisees opened 11 and closed 31 centers in fiscal 2025. System-wide sales of $947.3 million decreased 0.4% from $951.0 ...

The focus is shifting from accountability to learning. by Peter Cappelli and Anna Tavis When Brian Jensen told his audience of HR executives that Colorcon wasn’t bothering with annual reviews anymore, ...

If you were to ask your colleagues, “Who was Paul Revere?” most would probably know the answer. He was, after all, immortalized in the Longfellow poem that begins, “Listen, my children, and you shall ...

Monroe Capital Corporation (NASDAQ: MRCC) today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Board of Directors (the 'Board') also declared its ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).